Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Selenoprotein T (SELENOT) is a highly conserved, endoplasmic reticulum-resident selenoprotein containing a selenocysteine residue and functioning as an oxidoreductase. It plays a critical role in cellular redox regulation, maintaining calcium homeostasis in the ER, and modulating ER stress responses. SELENOT is essential for proper brain development, neuroprotection, and cell survival, as supported by lethality in knockout models. SELENOT is also implicated in the regulation of apoptosis, cell proliferation, glycoprotein N-glycosylation, and protein quality control. Alterations in its expression or function are linked to neurodegenerative diseases, ER stress-related conditions, and cancer. While some selenium-based compounds interact with and modulate SELENOT expression, no approved selective pharmacological inhibitors or activators are currently documented; nonetheless, SELENOT is considered a potential target for drug development in redox and ER stress-associated diseases.
Modulation of redox state, regulation of calcium storage in the ER, and modulation of ER stress and unfolded protein response.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Selenoprotein T (SELENOT).